We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Years into a standoff between Vertex Pharmaceuticals and NHS England over cystic fibrosis drug prices, the company's top brass is set to participate in a parliamentary hearing focused on pricing negotiations.